Novo Nordisk announced it is cutting ties with telehealth giant Hims & Hers Health, pulling its blockbuster drug Wegovy from the platform after accusing the company of selling “illegitimate, knockoff ...

The FDA has issued a warning as fake Ozempic have started circulating amid a recent trend seeing people using the diabetes ...

Obesity increases the risk of nearly 200 diseases. A new genetic test may be able to predict a young child's risk of obesity ...

AstraZeneca said it would invest $50 billion in U.S. production by 2030. At the core is a manufacturing plant to go somewhere ...

GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health ...

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...

Later that day, a quieter ePoster session titled Obesity-Associated Diabetes and Cancer Risk offered a chilling insight: Type 2 diabetes is tied not only to heart disease, but also to several cancers, ...

Rhythm Pharmaceuticals develops medicines for rare disorders that cause weight gain. The company's only approved product is ...

Fangzhou & Novo Nordisk sign MoU to establish a new ecosystem for health management: Beijing Monday, July 21, 2025, 17:00 Hrs [IST] Fangzhou Inc., a leader in Internet healthcare ...

The joint effort will focus on providing patients with medication guidance, reminders, tracking of efficacy and health education.

Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...